Inhaled nitric oxide and inhaled prostaglandin E1: Effect on left ventricular contractility when used for treatment of experimental pulmonary hypertension

European Journal of Cardio-thoracic Surgery

Volumn 14, Issue 5, 1998, Pages 494-502

  Krieg, Peter ^a   Wahlers, Thorsten ^a   Giess, Wolfgang ^a   Rohde, Roland ^a   Hartrumpf, Martin ^a   Bund, Michael ^a   Haverich, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Inhalation of Drugs; Left ventricular function; Nitric oxide; Prostaglandin E1; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE; PROSTAGLANDIN E1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FUNCTION; HEART PRELOAD; INHALATIONAL DRUG ADMINISTRATION; INOTROPISM; LUNG CAPILLARY PRESSURE; LUNG CIRCULATION; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REPERFUSION INJURY; SWINE;

ADMINISTRATION, INHALATION; ALPROSTADIL; ANIMALS; DRUG THERAPY, COMBINATION; HYPERTENSION, PULMONARY; MYOCARDIAL CONTRACTION; NITRIC OXIDE; RANDOM ALLOCATION; STROKE VOLUME; SWINE; VENTRICULAR FUNCTION, LEFT;

EID: 0032211702     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(98)00210-3     Document Type: Article

References (25)

1. Kaye M.P. The Registry of the International Society for Heart and Lung Transplantation: tenth official report - 1993. J Heart Lung Transplant. 12:1993;541-548.
2. Wahlers T., Beer C., Fieguth H.G.et al. Right heart failure following orthotopic cardiac transplantation. Clin Transplant. 2:1988;252-256.
3. Moraes D., Loscalzo J. Pulmonary hypertension: newer concepts in diagnosis and management. Clin Cardiol. 20:1997;676-682.
4. 1) in combination with nitric oxide (NO) for the treatment of pulmonary hypertension - a new strategy in thoracic organ transplantation? Langenbecks Arch Chir. Suppl I:1996;285-290.
5. Pepke Zaba J., Higenbottam T.W., Dinh Xuan A.T., Stone D., Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 338:1991;1173-1174.
6. 1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study. Crit Care Med. 7:1994;1084-1090.
7. Loh E., Stamler J.S., Hare J.M., Loscalzo J., Colucci W.S. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation. 90:1994;2780-2785.
8. Hayward C.S., Rogers P., Keogh A.M., Kelly R., Spratt P.M., MacDonald P.S. Inhaled nitric oxide in cardiac failure: vascular versus ventricular effects. J Cardiovasc Pharmacol. 27:1996;80-85.
9. Bocchi E.A., Bacal F., Auler J.O.C.J., Carmone M.J., Bellotti G., Pileggi F. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol. 74:1994;70-73.
10. Hare J.M., Loh E., Creager M.A., Colucci W.S. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 92:1995;2198-2203.
11. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., Simmons R.L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389.
12. Xie Y.W., Shen W., Zhao G., Xu X., Wolin M.S., Hintze T.H. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circ Res. 79:1996;381-387.
13. Hayward C.S., Kalnins W.V., Rogers P., Feneley M.P., MacDonald P.S., Kelly R.P. Effect of inhaled nitric oxide on normal human left ventricular function. J Am Coll Cardiol. 30:1997;49-56.
14. Chen E.P., Bittner H.B., Davis R.D., Van Trigt P. Effects of nitric oxide after cardiac transplantation in the setting of recipient pulmonary hypertension. Ann Thorac Surg. 63:1997;1546-1555.
15. Glower D.D., Spratt J.A., Snow N.D., Kabas J.S., Davis J.W., Olsen C.O., Tyson G.S., Sabiston D.C.J., Rankin J.S. The linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation. 71:1985;994-1009.
16. Feneley M.P., Olsen C.O., Glower D.D., Rankin J.S. Effect of acutely increased right ventricular afterload on work output from the left ventricle in conscious dogs. Systolic ventricular interaction. Circ Res. 65:1989;135-145.
17. Paulus W.J., Vantrimpont P.J., Shah A.M. Paracrine coronary endothelial control of left ventricular function in humans. Circulation. 92:1995;2119-2126.
18. Goldstein D.J., Dean D.A., Smerling A., Oz M.C., Burkhoff D., Dickstein M.L. Inhaled nitric oxide is not a negative inotropic agent in a porcine model of pulmonary hypertension. J Thorac Cardiovasc Surg. 114:1997;461-466.
19. Holubarsch C, Pieske B, Hasenfuss G. Pathologic versus adaptional alterations of hypertrophied and failing human myocardium. In: Nagano M, Takeda N, Dhalla NS, eds. The Adapted Heart. New York: Raven Press, 1994;3-14.
20. Pieske B., Kretschmann B., Meyer M., Holubarsch C., Weirich J., Posival H., Minami K., Just H., Hasenfuss G. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation. 92:1995;1169-1178.
21. 2+ATPase in failing and non-failing human myocardium. Circ Res. 75:1994;434-442.
22. Flesch M., Kilter H., Cremers B., Lenz O., Südkamp M., Kuhn-Regnier F., Böhm M. Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. J Pharmacol Exp Ther. 281:1997;1340-1349.
23. Shah AM, Silverman HS, Griffiths EJ, Spurgeon HA, Lakatta EG. cGMP prevents delayed relaxation at reoxygenation after brief hypoxia in isolated cardiac myocytes. Am J Physiol 1995;268:H2396-204.
24. 1, and sodium nitroprusside. J Heart Lung Transplant. 14:1995;436-443.
25. Jia L., Bonaventura J., Stamler J.S. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control [see comments]. Nature. 380:1996;221-226.